Eline Tommelein1, Mirko Petrovic2, Annemie Somers3, Els Mehuys1, Tischa van der Cammen4, Koen Boussery1. 1. Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, Gent B-9000, Belgium. 2. Department of Internal Medicine, Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, Gent B-9000, Belgium. 3. Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, Gent B-9000, Belgium Department of Pharmacy, Ghent University Hospital, De Pintelaan 185, Gent B-9000, Belgium. 4. Department of Internal Medicine, Section of Geriatric Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Abstract
BACKGROUND: Ageing of the population often leads to polypharmacy. Consequently, potentially inappropriate prescribing (PIP) becomes more frequent. Systematic screening for PIP in older patients in primary care could yield a large improvement in health outcomes, possibly an important task for community pharmacists. In this article, we develop an explicit screening tool to detect relevant PIP that can be used in the typical community pharmacy practice, adapted to the European market. METHODS: Eleven panellists participated in a two-round RAND/UCLA (Research and Development/University of California, Los Angeles) process, including a round zero meeting, a literature review, a first written evaluation round, a second face-to-face evaluation round and, finally, a selection of those items that are applicable in the contemporary community pharmacy. RESULTS: Eighteen published lists of PIP for older patients were retrieved from the literature, mentioning 398 different items. After the two-round RAND/UCLA process, 99 clinically relevant items were considered suitable to screen for in a community pharmacy practice. A panel of seven community pharmacists selected 83 items, feasible in the contemporary community pharmacy practice, defining the final GheOP³S tool. CONCLUSION: A novel explicit screening tool (GheOP³S) was developed to be used for PIP screening in the typical community pharmacy practice.
BACKGROUND: Ageing of the population often leads to polypharmacy. Consequently, potentially inappropriate prescribing (PIP) becomes more frequent. Systematic screening for PIP in older patients in primary care could yield a large improvement in health outcomes, possibly an important task for community pharmacists. In this article, we develop an explicit screening tool to detect relevant PIP that can be used in the typical community pharmacy practice, adapted to the European market. METHODS: Eleven panellists participated in a two-round RAND/UCLA (Research and Development/University of California, Los Angeles) process, including a round zero meeting, a literature review, a first written evaluation round, a second face-to-face evaluation round and, finally, a selection of those items that are applicable in the contemporary community pharmacy. RESULTS: Eighteen published lists of PIP for older patients were retrieved from the literature, mentioning 398 different items. After the two-round RAND/UCLA process, 99 clinically relevant items were considered suitable to screen for in a community pharmacy practice. A panel of seven community pharmacists selected 83 items, feasible in the contemporary community pharmacy practice, defining the final GheOP³S tool. CONCLUSION: A novel explicit screening tool (GheOP³S) was developed to be used for PIP screening in the typical community pharmacy practice.
Authors: Filipa Alves da Costa; Catarina Periquito; Maria Clara Carneiro; Pedro Oliveira; Ana Isabel Fernandes; Patrícia Cavaco-Silva Journal: Int J Clin Pharm Date: 2016-06-24
Authors: Eline Tommelein; Els Mehuys; Mirko Petrovic; Annemie Somers; Charlotte Van Damme; Eva Pattyn; Kristof Mattelin; Koen Boussery Journal: Int J Clin Pharm Date: 2016-08-08
Authors: Jenni Burt; Natasha Elmore; Stephen M Campbell; Sarah Rodgers; Anthony J Avery; Rupert A Payne Journal: BMC Med Date: 2018-06-13 Impact factor: 8.775
Authors: J Wuyts; J Maesschalck; I De Wulf; K Foubert; K Boussery; J De Lepeleire; V Foulon Journal: BMC Health Serv Res Date: 2018-08-08 Impact factor: 2.655
Authors: David John Wright; Vivienne Maskrey; Annie Blyth; Nigel Norris; David P Alldred; Christine M Bond; James Desborough; Carmel M Hughes; Richard Charles Holland Journal: Int J Pharm Pract Date: 2019-11-12